Kewaunee Scientific Corporation Common Stock (KEQU) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q4 23	—	$0.34	—	—	$54M	—
Q3 23	—	$0.25	—	—	$60.8M	—
Q2 23	—	-$0.09	—	—	$54.6M	—
Q1 23	—	-$0.27	—	—	$50.1M	—
Q4 22	—	-$0.13	—	—	$49.7M	—
Q3 22	—	-$0.47	—	—	$40.6M	—
Q2 22	—	-$1.11	—	—	$39M	—
Q1 22	—	-$0.48	—	—	$39.5M	—
Q4 21	—	-$1.08	—	—	$38.7M	—
Q3 21	—	$0.03	—	—	$33.3M	—
Q2 21	—	-$0.07	—	—	$39M	—
Q1 21	—	-$0.22	—	—	$36.4M	—
Q4 20	—	-$0.39	—	—	$34.3M	—
Q3 20	—	-$0.7	—	—	$34.2M	—
Q2 20	—	-$0.03	—	—	$39.7M	—
Q1 20	—	$0.17	—	—	$39.3M	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY26	—	$3.36	—	—	$282M	—
FY25	—	$3.98	—	—	$240.5M	—
FY24	—	$6.51	—	—	$203.8M	—
FY23	—	$0.26	—	—	$219.5M	—
FY22

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	$138.6M	$158.1M	$146.6M	$147.5M	$147.5M	$168.9M	$219.5M	$203.8M	$240.5M	$282M
YoY change	+7.72%	+14.1%	-7.28%	+0.68%	-0.05%	+14.5%	+30%	-7.17%	+18%	+17.3%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	138.6M	158.1M	146.6M	147.5M	147.5M	168.9M	219.5M	203.8M	240.5M	282M
Cost of revenue	112M	125.9M	121.2M	124.1M	123.5M	144.7M	183.9M	151.7M	171.6M	201.6M
Gross profit	26.6M	32.2M	25.3M	23.4M	24M	24.2M	35.6M	52.1M	68.9M	80.4M
Gross margin	19.2%	20.3%	17.3%	15.9%	16.3%	14.3%	16.2%	25.5%	28.6%	28.5%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	—	—	295K	454K	1.2M	—	71K	4.2M	—	—
Operating expenses	20.1M	22.2M	23.5M	26.2M	26.5M	26.8M	30.3M	37.9M	51.1M	63.7M
Operating income	6.5M	9.9M	2.1M	-2.3M	-1.3M	-2.6M	5.3M	14.1M	17.8M	16.7M
Operating margin	4.72%	6.28%	1.44%	-1.59%	-0.89%	-1.54%	2.41%	6.92%	7.39%	5.93%
Non-operating income, net	496K	-1K	389K	-28K	-912K	755K	939K	814K	240K	880K
Pretax income	6.7M	9.6M	2.1M	-2.9M	-2.6M	-2.5M	4.5M	13.1M	14.8M	13.7M
Income tax	2.1M	4.2M	446K	1.8M	990K	3.5M	3.1M	-5.9M	3.2M	3.3M
Net income	4.6M	5.5M	1.7M	-4.6M	-3.6M	-6M	1.4M	19.1M	11.6M	10.5M
Net margin	3.33%	3.45%	1.15%	-3.13%	-2.45%	-3.55%	0.62%	9.35%	4.82%	3.71%
EBITDA	9.7M	12.7M	5.1M	281K	459K	916K	9.1M	18M	22.8M	23.9M
EPS	1.67	1.91	0.56	-1.7	-1.33	-2.2	0.26	6.51	3.98	3.36
Diluted EPS	1.66	1.87	0.55	-1.7	-1.33	-2.2	0.25	6.38	3.83	3.22

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27
Revenue	50.4M	46.8M	56.7M	48.4M	47.8M	67.2M	77.1M	71.1M	70.1M	69.4M	71.4M	—
Cost of revenue	37M	34.7M	42.1M	35.9M	33.8M	48.8M	53.1M	50.2M	50.4M	50.9M	50.2M	—
Gross profit	13.5M	12M	14.6M	12.5M	14M	18.4M	24M	20.9M	19.7M	18.5M	21.2M	—
Gross margin	26.7%	25.7%	25.8%	25.8%	29.2%	27.4%	31.2%	29.4%	28.1%	26.7%	29.8%	—
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	40K	41K	4.1M	—	0	—	—	—	—	—	—	—
Operating expenses	8.4M	8.3M	13.1M	9.9M	9.5M	16.1M	15.5M	16.1M	15.6M	16M	16M	—
Operating income	5.1M	3.8M	1.5M	2.6M	4.4M	2.3M	8.5M	4.8M	4.1M	2.6M	5.2M	—
Operating margin	10.1%	8.05%	2.65%	5.32%	9.28%	3.35%	11%	6.76%	5.86%	3.72%	7.31%	—
Non-operating income, net	148K	161K	430K	327K	-61K	162K	-188K	168K	407K	134K	171K	—
Pretax income	4.8M	3.5M	1.3M	2.4M	3.9M	1.3M	7.1M	3.9M	3.5M	1.6M	4.8M	—
Income tax	2M	982K	-9.8M	192K	916K	-108K	2.2M	761K	915K	528K	1.1M	—
Net income	2.8M	2.5M	11.2M	2.2M	3M	1.4M	4.9M	3.2M	2.5M	1.1M	3.7M	—
Net margin	5.61%	5.41%	19.7%	4.62%	6.31%	2.06%	6.41%	4.44%	3.62%	1.55%	5.17%	—
EBITDA	6M	4.7M	2.8M	3.7M	5.2M	4M	9.9M	6.5M	6.1M	4.3M	6.9M	—
EPS	0.94	0.87	3.86	0.77	1.05	1.13	1.7	1.08	0.85	0.24	1.18	0.59
Diluted EPS	0.93	0.85	3.71	0.74	1.01	1.09	1.63	1.04	0.82	0.23	1.13	0.58

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Market cap	61.9M	95.1M	62.1M	28.1M	33.1M	39.7M	45.9M	102.8M	90.6M	106M	99.1M
Enterprise value	56.4M	91.7M	62.3M	37.7M	44.1M	44.7M	50.7M	90.5M	125.9M	126.2M	149.5M
Shares outstanding	2.7M	2.7M	2.7M	2.8M	2.8M	2.8M	2.8M	2.9M	2.9M	2.9M	2.9M

Valuation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
P/E	13.4	17.4	36.8	—	—	—	33.8	5.39	7.83	10.1	12.5
P/S	0.45	0.6	0.42	0.19	0.22	0.24	0.21	0.5	0.38	0.38	0.35
P/B	1.43	1.97	1.3	0.73	0.8	1.1	1.19	1.83	1.37	1.38	1.32
EV/EBITDA	5.79	7.23	12.3	134.1	96	48.8	5.58	5.02	5.53	5.29	6.5
EV/Sales	0.41	0.58	0.43	0.26	0.3	0.26	0.23	0.44	0.52	0.45	0.53
Earnings yield	7.46%	5.74%	2.72%	—	—	—	2.96%	18.5%	12.8%	9.88%	7.99%
FCF yield	14.6%	-0.22%	-2.78%	6.03%	-4.48%	-24.6%	-17.3%	14.8%	13.9%	13.9%	14.2%
PEG	—	—	—	—	—	—	—	—	—	—	-0.41

Profitability

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Gross margin	19.2%	20.3%	17.3%	15.9%	16.3%	14.3%	16.2%	25.5%	28.6%	28.5%	29.8%
Operating margin	4.72%	6.28%	1.44%	-1.59%	-0.89%	-1.54%	2.41%	6.92%	7.39%	5.93%	7.31%
Net margin	3.33%	3.45%	1.15%	-3.13%	-2.45%	-3.55%	0.62%	9.35%	4.82%	3.71%	3.41%
ROE	10.7%	11.3%	3.54%	-11.9%	-8.69%	-16.6%	3.53%	33.9%	17.5%	13.6%	14.6%
ROA	5.71%	6.41%	1.94%	-5.51%	-4.02%	-5.05%	1.14%	14.1%	5.95%	5.87%	5.6%
ROIC	11.9%	12.6%	3.48%	-4.86%	-2.51%	-6.33%	3.69%	32.1%	13.7%	13.1%	13.1%
Return on tangible assets	5.71%	6.41%	1.94%	-5.51%	-4.02%	-5.05%	1.14%	14.1%	8.64%	8.67%	8.67%

Financial health

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Current ratio	2.22	2.33	2	2	1.77	2.17	2.2	2.37	2.2	2.18	2.18
Quick ratio	1.67	1.66	1.47	1.44	1.29	1.6	1.65	1.87	1.59	1.55	1.55
Debt / equity	0.16	0.13	0.23	0.36	0.39	0.26	0.34	0.2	0.76	0.39	0.74
Debt / assets	0.09	0.07	0.13	0.17	0.18	0.08	0.11	0.08	0.26	0.17	0.17
Net debt / EBITDA	-0.57	-0.27	0.06	34	23.8	5.47	0.53	-0.68	1.55	0.85	0.85
Interest coverage	24.1	33.2	6.81	-4.81	-5.73	-2.93	3.59	8.29	5.6	4.56	4.56
Effective tax rate	31.5%	43.3%	20.9%	0%	0%	0%	69.8%	0%	21.7%	23.8%	23.8%

Per share

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Revenue per share	51.2	58.1	53.4	53.7	53.4	60.6	77.7	70.8	84	98.5	98.5
EPS (basic)	1.67	1.91	0.56	-1.7	-1.33	-2.2	0.26	6.51	3.98	3.36	3.36
EPS (diluted)	1.66	1.87	0.55	-1.7	-1.33	-2.2	0.25	6.38	3.83	3.22	2.76
Book value per share	16	17.7	17.4	14.1	15	13	13.6	19.5	23.1	26.8	26.1
FCF per share	3.35	-0.08	-0.63	0.62	-0.54	-3.52	-2.81	5.28	4.41	5.13	4.91
Cash per share	4.62	3.57	3.88	1.59	1.89	1.59	2.86	8.08	5.22	3.48	3.47
Capex per share	—	—	—	—	—	—	—	—	—	1.38	1.31

Capital allocation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Capex / revenue	—	—	—	—	—	—	—	—	—	1.4%	1.4%
Capex / operating cash flow	—	—	—	—	—	—	—	—	—	21.1%	21.1%
Payout ratio	34%	32.9%	120.3%	-22.6%	0%	—	—	—	—	—	0%
Dividend yield	2.53%	1.89%	3.27%	3.71%	0%	—	—	—	—	—	2.2%

Yield

2.2%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.19

ex-dividend Sep 9, 2019

Payout ratio

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Sep 9, 2019	$0.19
Jun 6, 2019	$0.19
Mar 8, 2019	$0.19

Period	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27
Revenue	$50.4M	$46.8M	$56.7M	$48.4M	$47.8M	$67.2M	$77.1M	$71.1M	$70.1M	$69.4M	$71.4M	—
YoY change	-7.57%	-23.1%	+5.03%	-2.9%	-5.3%	+43.6%	+36.1%	+46.9%	+46.8%	+3.32%	-7.45%	—

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Cash & short-term investments	12.5M	9.7M	10.6M	4.4M	5.2M	4.4M	8.1M	23.3M	14.9M	9.9M
Receivables	29.9M	32.7M	33.3M	28.1M	32.9M	41.3M	46.1M	45.1M	62.4M	58.7M
Inventory	14.9M	18.5M	17.2M	15.3M	16.5M	23.8M	21.9M	20.7M	32.8M	30.5M
Total current assets	59.8M	64.4M	65.4M	54.2M	60.5M	91.6M	87.9M	96.8M	118.4M	105.4M
Property, plant & equipment	-1.9M	-1.8M	-132K	8.7M	8.2M	5.5M	8.4M	7.8M	17.9M	14.1M
Goodwill & intangibles	—	—	—	—	—	—	—	—	60.6M	57.6M
Total assets	80.9M	85.1M	87.2M	83.9M	89.7M	118.8M	118.9M	134.8M	194.7M	178.3M
Accounts payable	12M	14.8M	15.2M	13.1M	16.8M	27.3M	23.6M	23.3M	27M	22.5M
Short-term debt	4.5M	5.1M	10.7M	6M	8.2M	3M	5.6M	5.3M	7.3M	8.8M
Total current liabilities	26.9M	27.6M	32.7M	27.1M	34.2M	42.3M	40.1M	40.8M	53.7M	48.4M
Long-term debt	2.4M	1.3M	229K	7.9M	8M	6.4M	7.3M	5.7M	42.9M	21.4M
Total liabilities	37.7M	36.9M	39.5M	45.2M	47.9M	82.6M	80.4M	78.6M	128.4M	101.5M
Shareholders' equity	43.3M	48.2M	47.7M	38.7M	41.5M	36.2M	38.5M	56.2M	66.2M	76.8M
Total debt	6.9M	6.3M	10.9M	13.9M	16.1M	9.4M	12.9M	11M	50.2M	30.2M
Net debt	-5.6M	-3.4M	279K	9.5M	10.9M	5M	4.8M	-12.3M	35.2M	20.2M

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Cash & short-term investments	12.7M	13.7M	21.3M	23.3M	24.2M	26M	9.5M	14.9M	19.5M	12.6M	8.2M	9.9M
Receivables	42.5M	42.6M	41.1M	45.1M	43.5M	41.9M	57.4M	62.4M	56.9M	59M	54.1M	58.7M
Inventory	22.1M	21.7M	21.8M	20.7M	19.3M	18.7M	31.6M	32.8M	34.9M	35.5M	32.9M	30.5M
Total current assets	93.5M	90.9M	96.2M	96.8M	92.7M	96.4M	108.6M	118.4M	117.1M	113.6M	103.6M	105.4M
Property, plant & equipment	26M	26.2M	25.3M	7.8M	24.1M	23.9M	37.8M	17.9M	34.8M	34.6M	33.1M	14.1M
Goodwill & intangibles	—	—	—	—	—	—	64.7M	60.6M	59.9M	59.1M	58.3M	57.6M
Total assets	124.8M	121.7M	126.3M	134.8M	132M	134.5M	189.1M	194.7M	193.5M	189.1M	176M	178.3M
Accounts payable	22.1M	19.2M	19.1M	23.3M	20.6M	21.5M	24.5M	27M	26.3M	22.7M	23.6M	22.5M
Short-term debt	7.1M	8.1M	5.3M	5.3M	5.8M	3M	7.6M	7.3M	6.6M	7.5M	9.7M	8.8M
Total current liabilities	44.2M	38.7M	42.1M	40.8M	36.7M	36.5M	50.2M	53.7M	50.5M	45.8M	48.8M	48.4M
Long-term debt	6.8M	6.5M	6M	5.7M	5.3M	5.2M	44.7M	42.9M	41.9M	39.2M	22.8M	21.4M
Total liabilities	84.3M	78.3M	81M	78.6M	74.5M	73.8M	127M	128.4M	124.6M	117.4M	103.4M	101.5M
Shareholders' equity	40.5M	43.4M	45.3M	56.2M	57.5M	60.7M	62.1M	66.2M	68.9M	71.7M	72.5M	76.8M
Total debt	13.8M	14.6M	11.3M	11M	11.1M	8.2M	52.3M	50.2M	48.5M	46.7M	32.5M	30.2M
Net debt	1.1M	834K	-10M	-12.3M	-13.1M	-17.7M	42.8M	35.2M	29M	34.1M	24.4M	20.2M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Net income	4.6M	5.5M	1.7M	-4.6M	-3.6M	-6M	1.4M	19.1M	11.6M	10.5M
Depreciation & amortization	2.7M	2.8M	2.6M	2.7M	2.7M	2.8M	2.9M	3.1M	4.8M	6.3M
Stock-based compensation	199K	355K	197K	251K	634K	729K	886K	1M	1.4M	2.1M
Change in working capital	3.2M	-11.5M	-2.2M	5.6M	-5.1M	-17.5M	-4M	2.5M	-2.6M	5M
Operating cash flow	10.9M	-1.8M	2.5M	5.8M	-3.7M	-19.9M	1.6M	18.6M	14.1M	18.6M
Capital expenditure	—	—	—	—	—	—	—	—	—	-3.9M
Investing cash flow	132K	193K	—	—	—	—	—	—	-28.7M	-3.9M
Dividends paid	-1.6M	-1.8M	-2M	-1M	0	—	—	—	—	—
Share repurchases	—	—	—	—	—	—	0	-2M	-1.6M	0
Financing cash flow	-53.9M	-61.3M	-54.6M	-71M	-58.1M	-53.6M	-43.7M	-151.6M	-68.2M	-36.6M
Net change in cash	-42.8M	-62.8M	-52.2M	-65.1M	-61.8M	-73.4M	-42M	-133M	-82.8M	-21.9M
Free cash flow	9.1M	-212K	-1.7M	1.7M	-1.5M	-9.8M	-7.9M	15.2M	12.6M	14.7M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Net income	2.5M	2.8M	2.5M	11.2M	2.2M	3M	1.4M	4.9M	3.2M	2.5M	1.1M	3.7M
Depreciation & amortization	718K	770K	817K	820K	815K	806K	1.6M	1.6M	1.5M	1.6M	1.6M	1.6M
Stock-based compensation	183K	241K	241K	363K	318K	373K	380K	370K	521K	561K	542K	502K
Change in working capital	4.8M	1.2M	5M	-8.5M	1.6M	3.5M	-4.2M	-3.4M	1.7M	-3.1M	7.1M	-675K
Operating cash flow	8.3M	5.1M	8.6M	-3.4M	4.3M	7.2M	-1.8M	4M	5.8M	-4.3M	11.6M	5.5M
Capital expenditure	—	—	—	—	—	—	—	—	-771K	-1.6M	-668K	-928K
Investing cash flow	—	—	—	—	—	—	—	0	-771K	-1.6M	-668K	-928K
Dividends paid	—	—	—	—	—	—	—	—	—	—	—	—
Share repurchases	—	—	—	-1.2M	—	—	—	-1.6M	—	—	—	—
Financing cash flow	-37.8M	-36.9M	-38.7M	-36.7M	-37.6M	-31.5M	6.9M	-5.8M	-3.3M	-1.8M	-25M	-6M
Net change in cash	-29.6M	-31.8M	-30.1M	-40.1M	-33.3M	-24.3M	5.1M	-1.8M	1.7M	-7.6M	-14.1M	-1.5M
Free cash flow	6.5M	-518K	9M	166K	-1.1M	7.8M	-3M	8.9M	5M	-5.8M	11M	4.5M

Date	Ratio
Jan 7, 1985	3:2
Jan 5, 1984	3:2

Kewaunee Scientific Corporation Common Stock Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement

Split history